Screener
Telomir Pharmaceuticals, Inc. TELO Q4 2025 Annual earnings
Reported March 17, 2026 · After market close
EPS-$0.06Beat by $0.01
EPS estimate-$0.07
Next report
Dec 2, 2026 (in a month)Revenue estimate$500.0K
EPS estimate-$0.03
Versus estimates
Diluted EPS
FAQ
- When did Telomir Pharmaceuticals, Inc. report Q4 2025 earnings?
- Telomir Pharmaceuticals, Inc. (TELO) reported Q4 2025 earnings on March 17, 2026 after market close.
- What were Telomir Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
- Telomir Pharmaceuticals, Inc. reported eps of $-0.06 for Q4 2025.
- Did Telomir Pharmaceuticals, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.07 by $0.01.
- How did Telomir Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 40.0% from $-0.10.
- Where can I find Telomir Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-010625) directly on SEC EDGAR. The filing index links above go to sec.gov.
